Skip to main content
Clinical Trials/JPRN-UMIN000035612
JPRN-UMIN000035612Completed未知

A verification study for the effect of the soybean milk beverage - A verification study for the effect of the soybean milk beverage

CPCC Company Limited0 sites120 target enrollmentStarted: January 27, 2019Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 64years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Subjects who are given continuous treatment by taking medicines. 2.Subjects who have taken medicines that may have influence to intestinal environment from a month before advance inspection. 3.Subjects who constantly use food for specified health use, functional foods, supplements, and/or healthy food having a possibility of affecting intestine regulatory action. 4.Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 5.Subjects who have previous and/or current medical history of serious disease. 6.Subjects who excessive alcohol intake. 7.Subjects who have previous and/or current medical history of drug dependence, alcohol dependence. 8.Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 9.Subjects who have previous medical history of drug and/or food, allergy, especially for milk and/or soybean milk. 10.Subjects who have constitution that tend to diarrhea if they intake dairy products and/or soybean milk products. 11.Subjects who are participating the other clinical tests, who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 12.Subjects who donated over 200mL blood and/or blood components within the last one month. 13.Males who donated over 400mL blood and/or blood components within the last three month. 14.Females who donated over 400mL blood and/or blood components within the last four month. 15.Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16.Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 17.Others who have been determined ineligible by principal investigator.

Investigators

Sponsor
CPCC Company Limited

Similar Trials